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Abstract Dolichyl monophosphate (Dol-P) has been found to
induce apoptosis in human leukemia U937 cells. During this
apoptotic execution, the increase of plasma membrane fluidity
(5^20 min), caspase-3-like protease activation (2^4 h), chromatin
condensation and DNA ladder formation (3^4 h) were observed
successively. Here, we report that reduction in mitochondrial
transmembrane potential and translocation of apoptosis-inducing
factor (AIF) are early events (1^3 h) in the apoptotic process
induced by Dol-P in U937 cells. The AIF was concentrated
around nuclei and partly translocated to the nuclei, which was
confirmed by immunocytochemistry using specific anti-AIF
antibody. Both caspase-8 and caspase-3 inhibitors blocked only
DNA fragmentation but not mitochondrial processes, AIF
migration and chromatin condensation. These results indicate
that mitochondrial changes are an early step in the apoptosis
induced by Dol-P and AIF is one of the important factors which
induce chromatin condensation in nuclei. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Apoptosis is associated with a number of distinct morpho-
logical changes including cell shrinkage, chromatin degrada-
tion, cytoplasmic and nuclear condensation and blebbing. Nu-
merous biochemical alterations are included in these
morphological alterations of the cells during apoptotic cell
death.
Recently, mitochondria have been shown to undergo a
number of profound changes early within the apoptotic pro-
gram and appear to play a central role in apoptosis in a
number of systems [1,2]. A reduction in mitochondrial trans-
membrane potential (v8m) is thought to be mediated by the
opening of the mitochondrial permeability transition pore
which includes a polyprotein complex, such as voltage-depen-
dent anion channel and adenine nucleotide translocator [3,4].
The v8m is regulated by the Bcl-2 family of proteins, whose
members may act as anti- or pro-apoptotic [5]. The reduction
of v8m induces liberation of apoptosis-inducing factor (AIF)
and release of cytochrome c from the mitochondrial inter-
membrane space to the cytosol [6^8]. The released AIF travels
to and accumulates in the nuclei, and activates chromatin
condensation at the nuclear periphery and cleavage of the
chromosomal DNA into large scale fragmentation. This fac-
tor does not act through downstream caspases [6,7]. The other
liberated substance, cytochrome c has been implicated in the
activation of the caspase cascade, such as caspase-9 and cas-
pase-3 [9]. Both two factors, AIF and cytochrome c play an
important role in apoptotic cell death.
Caspase proteinases drive apoptotic signaling and execution
by cleaving critical cellular proteins solely after aspartate res-
idues [10]. Caspases exist as latent zymogens, but apoptotic
death stimuli activate the initiator caspases, such as, caspase-8
and caspase-9. Once activated, initiator caspases in turn acti-
vate the executioner caspases, caspases-3, -6, and -7. The ac-
tive executioners promote apoptosis by cleaving cellular sub-
stances that induce the morphological and biochemical
features of apoptosis. Caspase-8 is recruited to a death-induc-
ing signaling complex when death receptors such as Fas or the
tumor necrosis factor receptor are oligomerized after binding
of speci¢c ligands. Active caspase-8 can act either directly on
downstream e¡ector caspases or indirectly on mitochondria.
Caspase-9, which is activated by binding to cytochrome c and
Apaf-1, cleaves and activates procaspase-3. The executioner
caspase, caspase-3 plays a central role in apoptotic DNA
fragmentation by inactivating DFF45/ICAD, thereby releas-
ing active DFF40/CAD [11].
Dolichyl monophosphate (Dol-P) is involved in the attach-
ment of carbohydrate chains to proteins in the formation of
N-linked glycoprotein [12]. We found that this compound in-
duces apoptosis in rat glioma C6 cells and human monoblastic
leukemia U937 cells [13,14]. In Dol-P-treated U937 cells, in-
crease of membrane £uidity (5^20 min), increase of caspase-3-
like protease activity (2^4 h) and DNA ladder formation (3^4
h) were observed successively [13,15^17]. In this study, we
examined whether mitochondrial function is related to the
apoptosis induced by Dol-P in U937 cells. We also investi-
gated whether mitochondrial change is upstream in caspase
cascade using speci¢c caspase inhibitors of caspase-8 or -3.
The cells treated with Dol-P undergo to apoptosis accompa-
nied by loss of v8m. This mitochondrial disruption in these
cells is observed after 1 h of treatment. AIF gathered around
nuclear periphery (3 h) and chromatin condensation followed.
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These processes were carried out independently against cas-
pase-3 or -8 inhibitor. We conclude that Dol-P-mediated
death of U937 cells involves mitochondrial disruption includ-
ing AIF migration and that this mitochondrial change occurs
in early step of apoptotic pathway before caspase activation.
We also suggest that AIF might have a direct e¡ect on nuclei
without caspase activation, triggering chromatin condensa-
tion.
2. Materials and methods
2.1. Reagents
Dol-P (diammonium salt) was kindly synthesized by Dr. I. Yamatsu
(Serendip Research Institute, Tokyo, Japan). Dol-P was dissolved in
ethanol-dodecane (98:2, by volume), according to Ji et al. [18]. This
reagent was added to the culture medium at a ¢nal concentration of
6 WM. The concentration was calculated based on the average molec-
ular weight because this compound is a mixture with 17^21 isoprene
units. A rabbit anti-AIF polyclonal antibody was generated against
amino acids 151^200 of AIF [6]. Rhodamine-labeled anti-rabbit IgG
antibody was from Chemicon International Inc. (Temecula, CA,
USA). Rhodamine 123 and JC-1 (5,5P,6,6P-tetrachloro-1,1P,3,3P-tet-
raethyl benzimidazole carbon cyanine iodide) were obtained from
Molecular Probes Inc. (Eugene, OR, USA). Hoechst 33342 was pur-
chased from Sigma Chemical Co. (St. Louis, MO. USA) The tetra-
peptide caspase-3 inhibitor, acetyl-Asp-Glu-Val-Asp-aldehyde
(DEVD-CHO) and caspase-8 inhibitor, acetyl-Ile-Glu-Thr-Asp-alde-
hyde(IETD-CHO) were obtained from Peptide Institute, Inc. (Osaka,
Japan). RNase was purchased from Wako Pure Chemical Co. (Osaka,
Japan).
2.2. Cell culture
The human promonocytic leukemia cell line U937 was grown in
RPMI 1640 medium (Gibco BRL, Grand Island, NY, USA) supple-
mented with 10% fetal calf serum (FCS) (JRH Biosciences, Lenexa,
KS, USA) at 37‡C in an atmosphere of 5% CO2. 400 Wl of cell
suspension (1.25U106 cells/ml) in RPMI 1640 medium containing
10% FCS was placed to each well of a 24-well plate. Dol-P (6 WM)
was added to the culture medium and mixed well with the medium,
with shaking. The cells were incubated for 1 or 3 h and harvested for
experiments. To examine the e¡ect of caspase inhibitors, the cells were
treated with inhibitor for 2 h prior to Dol-P treatment.
2.3. Morphological evaluation of cells and nuclei
Cell morphology was observed by light microscope (Olympus BX-
50, Tokyo, Japan) with Nomarski di¡erentiated interference contrast.
For detection of chromatin condensation, cells were stained with
Hoechst 33342 at ¢nal concentration of 4 Wg/ml in phosphate-bu¡ered
saline (PBS) and examined using £uorescent microscope (Olympus
BX-50).
2.4. Detection of fragmented DNA
Fragmented, apoptotic nuclei were recognized by their sub-diploid
DNA content. Brie£y, cells were washed with PBS, ¢xed with 80% ice-
cold ethanol and stocked at 320‡C. For analysis of DNA, ¢xed cells
were treated with RNase (100 Wg/ml) for 30 min at 37‡C and stained
with 50 Wg/ml of propidium iodide. Cell cycle analysis was performed
by Becton Dickinson FACS Calibur (Nippon Becton Dickinson Co.,
Tokyo, Japan) and the number of cells in the area corresponding to
the sub-G1 region was calculated using the CELLQuest program
(Nippon Becton Dickinson Co.).
2.5. Measurement of mitochondrial transmembrane potential (v8m)
To measure v8m, rhodamine 123 and JC-1 were used. Dol-P-
treated cells were washed with PBS, and were stained with rhodamine
123 or JC-1 at the same ¢nal concentration of 5 Wg/ml for 30 min at
37‡C. Samples stained with rhodamine 123 were subjected to £owcy-
tometry and those stained with JC-1 were used for observation of
£uorescent microscopy (Olympus BX-50). Flowcytometry was oper-
ated by Becton Dickinson FACS Calibur with an excitation wave-
length of 488 nm. The emission wavelength was detected through
the FL1 channel. Data were acquired and analyzed with CELLQuest
software.
2.6. Analysis of intracellular localization of AIF by
immunocytochemistry
Cells were harvested, rinsed once with PBS. Cells were ¢xed with
4% paraformaldehyde containing with 0.19% picric acid in PBS for 1 h
at room temperature and were permeabilized with 0.1% sodium
dodecyl sulfate. The permeabilized cells were blocked with 10% FCS
in PBS. The cells were dropped and mounted on a slide glass coated
with 3-aminopropyltriethoxysilane (Matsunami Glass Ind., Ltd., Osa-
ka, Japan). The slide glass was incubated with anti-AIF antibody
diluted 1:250 in PBS containing 0.5% bovine serum albumin (BSA)
for 40 min at 37‡C in a humidi¢ed chamber. Excess antibody binding
was removed by washing the slide glass with PBS. The secondary
antibody, rhodamine-labeled anti-rabbit IgG antibody, was added
and incubated for 30 min at 37‡C. After washing with PBS, photo-
labeled cells were analyzed using a £uorescent microscope (Olympus
BX-50) and a laser scanning confocal microscope (Olympus FV500).
3. Results and discussion
3.1. Reduction in mitochondrial transmembrane potential
The loss of the mitochondrial transmembrane potential
(v8m) has been identi¢ed as common early events occurring
in apoptosis induced by a variety of stimuli [19,20]. To inves-
tigate whether a reduction in v8m might relate to apoptosis
induced by Dol-P, v8m was monitored by £uorescence of the
potential-sensitive dye, rhodamine 123, by £ow cytometry. In
control cells treated for 3 h with solvent (0.8% ethanol:dode-
cane (98:2)), v8m showed high potential (Fig. 1A). However,
after 1 h of incubation with Dol-P (6 WM), rhodamine 123-
stained cells were separated to two populations by £uorescent
strength and 21% of cells showed a drastic reduction of the
v8m (Fig. 1B). After 3 h of treatment, the low v8m group of
cells increased to 50% (Fig. 1C). In order to examine the
involvement of caspases during this reduction in v8m, cells
were pretreated for 2 h with caspase inhibitors before adding
Dol-P. Both inhibitors of caspase-3 and -8 (400 WM) had no
e¡ect on the reduction of v8m (Fig. 1D,E).
Salvioli et al. reported that JC-1, cationic lipophilic dye, is a
reliable probe for analyzing v8m with £ow cytometry, while
the rhodamine 123 shows a low sensitivity in U937 cells [21].
Then, we attempted to use JC-1 to monitor v8m with £uo-
rocytochemistry and £ow cytometry. JC-1 is a mitochondrial
speci¢c dye and forms aggregates (590 nm) at the normal
membrane potential. A loss in v8m can be monitored as a
increase in JC-1 monomers (527 nm) [22]. As shown in Fig.
1F, JC-1 was avidly accumulated in sensitive control cells
where it displayed a bright £uorescence as higher potentials.
In contrast, JC-1 was poorly accumulated in Dol-P-treated
cells which displayed only a slight £uorescence as low mem-
brane potential (Fig. 1G). The £ow cytometric data of JC-1
staining cells after treatment of Dol-P were almost the same as
those of rhodamine 123 staining cells (data not shown).
Recently, our group reported that increase of plasma mem-
brane £uidity was observed 5^20 min after Dol-P treatment in
U937 cells [15]. The reduction of v8m (1^3 h) is the second
step in the apoptotic pathway and it is independent of cas-
pase-3 or caspase-8 activation. Presumably, treatment with
Dol-P triggered mitochondrial membrane perturbation and
resulted in the reduction of v8m.
3.2. Translocation of AIF in Dol-P-treated cells
Susin et al. reported that the reduction of v8m in mito-
chondria causes the release of AIF from the intermembrane
space to the cytosol followed by its translocation to the nu-
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cleus [6]. Then, we examined the cellular localization of AIF
in U937 cells during Dol-P-induced apoptosis by immuno-
£uorescent detection (Fig. 2). In control cells after 3 h of
treatment with solvent, AIF displayed cytoplasmic staining,
which is in agreement with its localization in mitochondria
(Fig. 2A). After 3 h of apoptosis induction by Dol-P, apopto-
tic cells exhibited mostly condense AIF staining with bright
spots in the perinuclear region (Fig. 2B). It suggests that mi-
tochondria became clustered around the nuclei. This phenom-
enon has recently been proposed as early characteristic event
during the occurrence of apoptosis [23^25]. In Fig. 2B, strong
bright AIF immunostaining in the nuclei was also observed in
a part of the apoptotic cells. However, the percentage of cells
manifesting mitochondrion-nuclear AIF translocation was
very low, less than 5%. These results were con¢rmed by con-
focal microscopy (data not shown). The inhibitors of caspase-
3 and -8 did not a¡ect perinuclear clustering of mitochondria
and the AIF immunostaining around the nuclei (Fig. 2C,D).
The e¡ect of caspase inhibitors on AIF translocation to nuclei
could not be evaluated because the number of AIF-translo-
cated nuclei were not frequent even among caspase inhibitor-
untreated cells. These data indicate apparently that AIF was
concentrated around the nuclei and partly translocated to the
nuclei in U937 cells during the apoptotic pathway induced by
Dol-P. The AIF immunostaining at peripheral nuclei was in-
dependent of caspase-3 or -8 activation.
3.3. Morphological changes of nuclei and DNA fragmentation
induced by Dol-P
Previously, we demonstrated that caspase-3 inhibitor
blocked DNA ladder formation in U937 cells treated with
dihydroprenyl monophosphate [16,17]. In this study, we in-
vestigated the e¡ects of caspase-3 or -8 inhibitor on nuclear
morphological changes in Dol-P-treated cells (Fig. 3). In Fig.
3B, nuclei staining with Hoechst 33342 of Dol-P treated cells
(3 h) showed apparent chromatin fragmentations. When U937
cells were pretreated with caspase-3 or -8 inhibitor followed
by Dol-P treatment, deformation of nuclei and chromatin
condensation but not chromatin fragmentation were observed
(Fig. 3C,D). These results suggest that some apoptotic signal
can induce chromatin condensation without caspase-3 or -8
activation in U937 cells. Susin et al. reported that AIF injec-
tion into cytoplasm-induced peripheral condensation of chro-
matin and microinjection of anti-AIF antibodies blocked this
Fig. 2. Immuno£uorescent detection of AIF in U937 cells treated
with Dol-P. Cells were treated with solvent (ethanol:dode-
cane = 98:2) for 3 h (A), Dol-P (6 WM) for 3 h (B), caspase-3 inhibi-
tor (400 WM) and Dol-P (6 WM) for 3 h (C), caspase-8 inhibitor
(400 WM) and Dol-P (6 WM) for 3 h (D). The cells were stained
with rabbit anti-AIF antibody which were detected with rhodamine-
conjugated anti-rabbit IgG antibody.
Fig. 1. Decrease of the mitochondrial membrane potential. U937 cells were stained with rhodamine 123 and v8m was monitored by £ow cyto-
metry. Cells treated with solvent (ethanol:dodecane = 98:2) for 3 h (A), Dol-P (6 WM) for 1 h (B) and Dol-P (6 WM) for 3 h (C). The e¡ects of
caspase-3 and -8 inhibitors on mitochondrial membrane potential during Dol-P-induced apoptosis are shown in (D) (caspase-3 inhibitor, 400
WM) and (E) (caspase-8 inhibitor, 400 WM), respectively. The mitochondrial membrane potential was visualized by JC-1 staining. Cells were
stained with JC-1 and observed by £uorescent microscope. The bright spots in the cytoplasm are mitochondria with higher membrane potential
and weak £uorescence exists as a monomer of JC-1 at low membrane potential. U937 cells were treated with solvent for 1 h (F) or Dol-P for
1 h (G).
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condensation [6]. They also indicated that AIF is independent
of the caspase cascade. Thus, chromatin condensation induced
by Dol-P in the presence of caspase-3 or -8 inhibitor might
depend on AIF stimuli.
Dol-P induced DNA ladder formation in U937 cells con-
¢rmed by agarose gel electrophoresis [13]. In this experiment,
we analyzed DNA fragmentation by FACS analysis for cal-
culating the percentage of the sub-G1 population. Dol-P in-
duced increment of sub-G1 population of U937 cells in a time-
dependent manner, such as 10% of the sub-G1 population
after 1 h and 28% after 3 h of treatment (Fig. 3E^G). This
DNA fragmentation was signi¢cantly inhibited by both cas-
pase-3 and -8 inhibitors (Fig. 3H). The inhibition of DNA
fragmentation by caspase-3 inhibitor was more prominent
than that by caspase-8 inhibitor. Wang and Nagata’s groups
independently puri¢ed nuclease DFF40/CAD which is acti-
vated by caspase-3 and results in DNA fragmentation
[26,27]. Healthy cells contain a heterodimer comprised of
DFF40/CAD and DFF45/ICAD. Caspase-3 activates the
DFF40/CAD by cleaving the inhibitor DFF45/ICAD at two
sites. The activated CAD/DFF40 provides internucleosomal
DNA degradation. Therefore, DNA fragmentation induced
by Dol-P might depend on the activation of CAD/DFF40
and this is downstream of the caspase cascade.
Conclusively, these results indicate that apoptosis induced
by Dol-P stimulates a decline in v8m, AIF condensation at
the peripheral nuclei and translocation of AIF to the nuclei.
This occurs not downstream of caspase-8 and -3 in U937 cells.
However, the translocation of AIF to the nuclei was observed
in a part of apoptosis-induced cells, but not in all cells. On the
contrary, nuclear condensation occurred in the most of Dol-P
treated cells. These ¢ndings suggest that undetectable levels of
AIF translocated into nuclei e¡ectively induce chromatin con-
densation of U937 cells. Alternatively, it might be considered
that other factors than existence of AIF in cytosol or mito-
chondria induce chromatin condensation and work independ-
ently of the caspase cascade.
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Fig. 3. E¡ects of caspase-3 or caspase-8 inhibitor on nuclear mor-
phology and DNA fragmentation. U937 cells were stained with
Hoechst 33342 and observed by £uorescent microscope. Cells were
treated with solvent (ethanol:dodecane = 98:2) for 3 h (A), Dol-P (6
WM) for 3 h (B), caspase-3 inhibitor (400 WM) and Dol-P (6 WM)
for 3 h (C), caspase-8 inhibitor (400 WM) and Dol-P (6 WM) for 3 h
(D). Fragmented DNA (sub-G1 population) were stained with pro-
pidium iodide and analyzed by £ow cytometry. U937 cells were
treated with solvent for 3 h (E), Dol-P (6 WM) for 1 h (F), Dol-P (6
WM) for 3 h (G). E¡ects of caspase-3 inhibitor, DEVD-CHO (400
WM) or caspase-8 inhibitor, IETD-CHO (400 WM) on the sub-G1
population induced by Dol-P (H). Student’s t-test was used for sta-
tistical analysis. **P6 0.01, ***P6 0.001
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